Form 4: Medpace Director Brian Carley Reports Routine RSU Conversion and Share Acquisition
Insider Transaction Report
Medpace Holdings, Inc. Director Brian T. Carley reported the acquisition of 62 shares of common stock through the conversion of restricted stock units, increasing his direct beneficial ownership to 26,157 shares.
Summary
- Brian T. Carley, a Director of Medpace Holdings, Inc. (MEDP), reported a transaction on June 30, 2025.
- The transaction involved the acquisition of 62 shares of Medpace common stock.
- These shares were acquired through the conversion of restricted stock units (RSUs) at a price of $0 per share.
- Following this transaction, Mr. Carley directly beneficially owns 26,157 shares of Medpace common stock.
- He also holds 124 restricted stock units.
- The original grant of 249 restricted stock units occurred on November 29, 2024, with vesting scheduled in four approximately equal installments on March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025.
Sentiment
Score: 7
Explanation: The filing is a routine disclosure of an insider's equity compensation vesting and conversion, which is a neutral event. The continued holding of a significant number of shares by a director is generally viewed as a positive alignment of interests.
Positives
- Director Brian T. Carley continues to hold a significant number of shares (26,157) in Medpace Holdings, Inc., aligning his interests with shareholders.
- The conversion of restricted stock units into common stock is a routine event, indicating the vesting of previously granted equity compensation.
Negatives
- NA
Risks
- NA
Future Outlook
NA
Management Comments
- NA
Industry Context
NA
Comparison to Industry Standards
- NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
Legal Proceedings
- NA
Related Party Transactions
- NA
Stakeholder Impact
- Shareholders: The transaction indicates a director's continued equity stake, aligning their interests with shareholders. It is a routine compensation event and does not directly impact company operations or financial performance.
Next Steps
- Future vesting of remaining restricted stock units on September 30, 2025, and December 31, 2025.
Key Dates
| Date | Description |
|---|---|
| 11/29/2024 | Reporting Person was granted 249 restricted stock units. |
| 03/31/2025 | First approximate vesting installment date for restricted stock units. |
| 06/30/2025 | Transaction date for the acquisition of 62 common shares from RSU conversion; Second approximate vesting installment date for restricted stock units. |
| 07/02/2025 | Signature date of the filing. |
| 09/30/2025 | Third approximate vesting installment date for restricted stock units. |
| 12/31/2025 | Fourth approximate vesting installment date for restricted stock units. |
Keywords
Medpace Holdings, MEDP, Brian T. Carley, Director, Insider Transaction, Form 4, Restricted Stock Units, RSU, Common Stock, Share Acquisition, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.